NCT05484245 Sonography-guided Resection of Brain Mass Lesions
| NCT ID | NCT05484245 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sklifosovsky Institute of Emergency Care |
| Condition | Tumor, Brain |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2022-09-01 |
| Primary Completion | 2027-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2022-09-01 with a primary completion date of 2027-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Objective of the study is to determine possibilities of intraoperative sonography in detecting of various brain mass lesions, assessing extent of their resection and define indications to use ultrasound-guided needle or ultrasound wire-guided port.
Eligibility Criteria
Inclusion Criteria: * all intracranial tumors * cavernomas * arteriovenous malformations * spontaneous (non-traumatic) intracerebral hemorrhages * traumatic intracerebral hemorrhages * supratentorial localization * newly diagnosed * age 18-100 years * stable hemodynamics Exclusion Criteria: * rapid cerebral dislocation * previously performed brain radiotherapy
Contact & Investigator
Alexander Dmitriev, MD
PRINCIPAL INVESTIGATOR
Sklifosovsky Institute of Emergency Care
Frequently Asked Questions
Who can join the NCT05484245 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Tumor, Brain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05484245 currently recruiting?
Yes, NCT05484245 is actively recruiting participants. Contact the research team at dmitriev@neurosklif.ru for enrollment information.
Where is the NCT05484245 trial being conducted?
This trial is being conducted at Moscow, Russia.
Who is sponsoring the NCT05484245 clinical trial?
NCT05484245 is sponsored by Sklifosovsky Institute of Emergency Care. The principal investigator is Alexander Dmitriev, MD at Sklifosovsky Institute of Emergency Care. The trial plans to enroll 100 participants.